Everest Organics Current Share Price | Everest Organics Stock Screener
EVERESTO
Pharmaceuticals
Everest Organics Current Stock Price Today
Live Share Price BSE
₹251.05
▲
0.55 (0.22%)
As of September 18, 2026, the live Everest Organics share price (BSE: EVERESTO) is ₹251.05, up 0.22% from the previous close, with shares trading between ₹250.50 and ₹254.80 in today's trading session, and a 52-week range of ₹203.45–₹522.50.
Browse EVERESTO income statement to support your investment research.
Use the Everest Organics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Everest Organics Market Cap
₹264.48 Cr.
EVERESTO P/E Ratio (TTM)
52.18
Everest Organics P/B Ratio
3.45
EPS (TTM)
₹5.70
Dividend Yield
-
Debt to Equity
0.91
EVERESTO 52 Week High
₹522.50
Everest Organics 52 Week Low
₹203.45
Operating Margin
10.00%
Profit Margin
2.60%
EVERESTO Revenue (TTM)
₹192.00
EBITDA
₹21.00
Net Income
₹5.00
Total Assets
₹240.00
Total Equity
₹76.00
Everest Organics Current Share Price Chart
Track the current Everest Organics share price and stock price with an interactive chart. Analyse EVERESTO price trends, trading volume, historical performance, and volatility across different timeframes — the complete Everest Organics stock quote in one place.
Everest Organics Company Profile - Fundamental Screener
Screen Everest Organics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for EVERESTO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE334C01029
Everest Organics Balance Sheet Screener
Screen EVERESTO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 240 | 225 | 227 | 202 | 178 | 135 | 120 | 107 | 94 | 86 |
| Current Assets | 167 | 148 | 150 | 133 | 118 | 89 | 79 | 67 | 58 | 49 |
| Fixed Assets | 68 | 50 | 52 | 55 | 49 | 44 | 39 | 39 | 34 | 33 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 12 | 15 | 21 | 18 | 19 | 11 | 12 | 10 | 8 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 76 | 70 | 46 | 46 | 47 | 47 | 34 | 26 | 19 | 16 |
| Share Capital | 10 | 10 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 66 | 59 | 38 | 38 | 39 | 39 | 26 | 18 | 11 | 8 |
Everest Organics Income Statement Screener - Profit & Revenue Analysis
Screen Everest Organics income statement and profit fundamentals.
Analyze EVERESTO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Everest Organics share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 192 | 196 | 160 | 198 | 190 | 202 | 183 | 169 | 156 | 113 | 108 | 100 | 107 |
| Expenses | 171 | 176 | 152 | 186 | 182 | 194 | 159 | 148 | 138 | 105 | 101 | 94 | 98 |
| EBITDA | 21 | 20 | 8 | 12 | 8 | 9 | 24 | 21 | 18 | 8 | 7 | 6 | 8 |
| Operating Profit % | 10.00% | 10.00% | 5.00% | 6.00% | 1.00% | 3.00% | 13.00% | 11.00% | 11.00% | 6.00% | 6.00% | 6.00% | 7.00% |
| Depreciation | 7 | 6 | 6 | 6 | 5 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 3 |
| Interest | 7 | 7 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 7 | 8 | -3 | 1 | 0 | 2 | 17 | 14 | 12 | 2 | 2 | 0 | 2 |
| Tax | 3 | 2 | -2 | 1 | 0 | 1 | 4 | 3 | 5 | 1 | 0 | 0 | 0 |
| Net Profit | 5 | 6 | -1 | 0 | 0 | 1 | 14 | 11 | 8 | 2 | 1 | 0 | 2 |
| EPS | 5.40 | 5.70 | -2.97 | 0.17 | -0.23 | 1.43 | 17.14 | 13.62 | 9.39 | 2.14 | 1.69 | 0.54 | 1.78 |
Everest Organics Cash Flow Screener - Liquidity Fundamentals
Screen EVERESTO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -5 | 16 | 18 | 14 | 14 | 10 | 9 | 5 | 10 | 7 |
| Investing Activities | -5 | -13 | -16 | -17 | -12 | -6 | -5 | -4 | -8 | -7 |
| Financing Activities | 16 | -3 | -3 | 2 | -2 | -3 | -3 | -1 | -2 | 0 |
| Net Cash Flow | 6 | 0 | 0 | -1 | 0 | 0 | 1 | 0 | 0 | 0 |
Everest Organics Shareholding Pattern Screener
See Everest Organics shareholding pattern with promoter, FII, and DII holdings.
Check Everest Organics promoter holding and ownership changes for EVERESTO on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Jan | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 59.58% | 59.60% | 61.09% | 61.09% | 60.99% | 59.64% | 59.61% | 74.15% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.06% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.91% | 26.95% | 32.22% | 23.87% | 25.35% | 25.98% | 26.10% | 20.00% |
| Other Holding | 13.48% | 13.42% | 6.67% | 15.02% | 13.64% | 14.35% | 14.26% | 5.79% |
| Shareholder Count | 7,880 | 7,827 | 8,795 | 8,756 | 8,281 | 8,079 | 7,804 | 10,023 |
Everest Organics Share Dividend Screener - Share Yield Analysis
Check Everest Organics dividend history with payout and yield data.
View Everest Organics dividend details including ex-dates and amounts for EVERESTO stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹1.50 | 0.86% |
| 2020-March | ₹1.00 | 0.43% |
| 2019-March | ₹1.00 | 1.05% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Everest Organics Stock Index Membership
See which indices include Everest Organics stock.
Check EVERESTO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Everest Organics Market Events Screener - Corporate Actions
Get Everest Organics corporate actions including splits, bonuses, and buybacks.
Check Everest Organics stock events that may affect EVERESTO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -12.65% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 1.25% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 3.65% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -0.90% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.21% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | 25.93% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -5.94% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | 7.42% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | 0.76% |
| 2025-01-08 | 2025-01-08 | Extraordinary General Meeting | NA | 36.35% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -6.74% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | -3.38% |
| 2022-09-15 | 2022-09-17 | Dividend | ₹ 0.50 /share | -6.05% |
| 2021-09-08 | 2021-09-11 | Dividend | ₹ 1.00 /share | -16.77% |
| 2021-02-17 | 2021-02-18 | Dividend | ₹ 0.50 /share | -9.19% |
Everest Organics Competitors Screener - Peer Comparison
Screen EVERESTO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Everest Organics Company Announcements - News Screener
Screen EVERESTO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-14 | Reg. 34 (1) Annual Report. | - |
| 2026-09-14 | Notice Of 33Rd Annual General Meeting And 33Rd Annual Report For The FY 2025-26 | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | Fixed The Cut-Off Date For The 33Rd Annual General Meeting Of The Company | - |
| 2026-08-14 | Fixes Book Closure For The 33Rd Annual General Meeting Of The Company | - |
| 2026-08-14 | The 33Rd Annual General Meeting (AGM) Of The Company Scheduled To Be Held On Wednesday September 30 2026 At 12.00 Noon (IST) Through Video Conferencing / Other Audio Visual Means (VC/OAVM). | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held Today | - |
| 2026-08-14 | Un-Audited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-06 | Board Meeting Intimation for Meeting Scheduled To Be Held On Friday August 14 2026 | - |
| 2026-07-11 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-06-22 | Announcement under Regulation 30 (LODR)-Cessation | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. May 29 2026. | - |
| 2026-05-29 | Audited Financials Results For The Quarter And Year Ended March 31 2026. | - |
| 2026-05-23 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |